D5 Logo (Tradjenta 5 mg)

Generic Name: linagliptin

Pill imprint D5 Logo has been identified as Tradjenta 5 mg.

Tradjenta is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Tradjenta 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tradjenta

Generic Name:

linagliptin

Imprint:

D5 Logo

Strength:

5 mg

Color:

Red

Shape:

Round

Availability:

Prescription only

Drug Class:

Dipeptidyl peptidase 4 inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Boehringer Ingelheim Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.